Market Cap 1.62B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 4,228,400
Avg Vol 7,203,780
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 1%
Beta 1.14
Analysts Strong Sell
Price Target $10.50

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
tradersunion353
tradersunion353 Jul. 28 at 2:42 PM
$ABCL clowns are back as this garbage drops they are start cheerleading with buying and loading commenrts 🤣🤣🤣
1 · Reply
tradersunion353
tradersunion353 Jul. 28 at 2:41 PM
$ABCL restless maggot pumpers how is that crazing adding and loading working
0 · Reply
nUme22
nUme22 Jul. 28 at 2:37 PM
$ABCL bought.. under 5 seems okay, but this could drop to 3-4 range as well. Will buy full position once it reaches under 4
1 · Reply
MrFish
MrFish Jul. 28 at 2:37 PM
$ABCL no brainer.
0 · Reply
DeMampCamp
DeMampCamp Jul. 28 at 2:34 PM
$ABCL Ok, enough is enough! They are gutting this before ER and our phase 2 readouts, incredibly frustrating!
2 · Reply
Rastafari
Rastafari Jul. 28 at 2:24 PM
$ABCL It’s why invest: hold folks. No panicking….this time next week all will be reversed!
0 · Reply
Gjhf2782
Gjhf2782 Jul. 28 at 2:19 PM
$ABCL Every fookin day…
1 · Reply
tradersunion353
tradersunion353 Jul. 28 at 1:52 PM
$ABCL clowns how is that adding and loading working?? the gift from heaven thise prices you were adding at 8,7,6 5 dollars?? 🤣🤣🤣🤣🤣
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 28 at 9:36 AM
$ABCL Pressure makes diamonds 😉👀
1 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 28 at 4:41 AM
$ABCL Carl just wants Canada to win “If we choose wisely, 20 years from now, we could have global companies - curing cancer, building new energy sources, high-tech, deep-tech businesses that move the country forward.” $ABCL
0 · Reply
Latest News on ABCL
AbCellera upgraded to Buy from Hold at Benchmark

2026-07-07T10:35:14.000Z - 21 days ago

AbCellera upgraded to Buy from Hold at Benchmark

JAZZ


AbCellera apponts Lynn Seely to board of directors

2026-07-06T13:15:29.000Z - 22 days ago

AbCellera apponts Lynn Seely to board of directors

LYEL


AbCellera Appoints Dr. Lynn Seely to its Board of Directors

Jul 6, 2026, 9:00 AM EDT - 22 days ago

AbCellera Appoints Dr. Lynn Seely to its Board of Directors


AbCellera appoints Victor Sandor to board of directors

2026-06-05T13:05:56.000Z - 7 weeks ago

AbCellera appoints Victor Sandor to board of directors


AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 2 months ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 3 months ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 3 months ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 5 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 5 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 6 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 9 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 9 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 11 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 1 year ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


tradersunion353
tradersunion353 Jul. 28 at 2:42 PM
$ABCL clowns are back as this garbage drops they are start cheerleading with buying and loading commenrts 🤣🤣🤣
1 · Reply
tradersunion353
tradersunion353 Jul. 28 at 2:41 PM
$ABCL restless maggot pumpers how is that crazing adding and loading working
0 · Reply
nUme22
nUme22 Jul. 28 at 2:37 PM
$ABCL bought.. under 5 seems okay, but this could drop to 3-4 range as well. Will buy full position once it reaches under 4
1 · Reply
MrFish
MrFish Jul. 28 at 2:37 PM
$ABCL no brainer.
0 · Reply
DeMampCamp
DeMampCamp Jul. 28 at 2:34 PM
$ABCL Ok, enough is enough! They are gutting this before ER and our phase 2 readouts, incredibly frustrating!
2 · Reply
Rastafari
Rastafari Jul. 28 at 2:24 PM
$ABCL It’s why invest: hold folks. No panicking….this time next week all will be reversed!
0 · Reply
Gjhf2782
Gjhf2782 Jul. 28 at 2:19 PM
$ABCL Every fookin day…
1 · Reply
tradersunion353
tradersunion353 Jul. 28 at 1:52 PM
$ABCL clowns how is that adding and loading working?? the gift from heaven thise prices you were adding at 8,7,6 5 dollars?? 🤣🤣🤣🤣🤣
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 28 at 9:36 AM
$ABCL Pressure makes diamonds 😉👀
1 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 28 at 4:41 AM
$ABCL Carl just wants Canada to win “If we choose wisely, 20 years from now, we could have global companies - curing cancer, building new energy sources, high-tech, deep-tech businesses that move the country forward.” $ABCL
0 · Reply
tradersunion353
tradersunion353 Jul. 28 at 12:49 AM
$ABCL question is how long company will hide about leaked bad phase 2 data…,
0 · Reply
tradersunion353
tradersunion353 Jul. 28 at 12:48 AM
$ABCL over hyped underperforming junk
0 · Reply
bonecrack_benny
bonecrack_benny Jul. 27 at 9:05 PM
$ABCL ❤️
0 · Reply
Samb2344
Samb2344 Jul. 27 at 8:21 PM
$ABCL ughh
0 · Reply
tradersunion353
tradersunion353 Jul. 27 at 8:03 PM
$ABCL disgusting pumpers
0 · Reply
tradersunion353
tradersunion353 Jul. 27 at 8:02 PM
$ABCL leaked bad phase 2 data - abcl 635 is really impacting the stock price not sure what this clowns are celebrating with adding loading comments
0 · Reply
Ckkung71
Ckkung71 Jul. 27 at 8:01 PM
$ABCL wow… one more day on no news…
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 27 at 7:27 PM
$ABCL Carl Hansen left a physics professorship to build $ABCL and still runs it more than a decade later. Technically deep founder, no quarterly theatre. In platform biotech the person choosing what to build matters more than the first molecule.
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 27 at 6:30 PM
$ABCL The June Jazz deal got read as $ABCL selling a drug. It did not. Jazz paid for access to the library of CD3 and costimulatory binders. You rent a catalog when the catalog is hard to rebuild. Platform proof, not a product sale.
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 27 at 6:28 PM
$ABCL $ABCL earns milestones and royalties on partner molecules it never funded through trials. Over 100 partner programs since 2014, around a dozen already in patients. Shots on goal that someone else paid for.
0 · Reply
Austinhilton
Austinhilton Jul. 27 at 4:14 PM
$SNDK over 11% after Morgan Stanley warns the memory boom is “approaching an inflection point” with contract chip prices expected to peak in late 2026. But a pricing peak doesn't necessarily mean an earnings peak because SanDisk has $42B in RPO from multiyear agreements with price floors near $0.29 per GB allowing contracted volume and rising AI storage demand to keep earnings growing even if NAND prices flatten. $ABCL $LEU
0 · Reply
tradersunion353
tradersunion353 Jul. 27 at 1:56 PM
$ABCL pos dropped 40% on leaked bad phase 2 abcl 635 data and clowns here are celebrating .. 🤮🤮🤮🤮
1 · Reply